Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Jul 27 (Reuters)-  
             Takara Bio Inc.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             6.36                6.31             33.20     
                 (+0.8 pct)          (+9.5 pct)       (+13.0 pct)  
  Operating        262 mln             643 mln            3.30     
                 (-59.2 pct)        (+476.3 pct)      (+3.0 pct)   
  Recurring        287 mln             653 mln            3.60     
                 (-56.0 pct)        (+200.2 pct)      (+0.6 pct)   
  Net              22 mln              285 mln            1.85     
                 (-92.0 pct)                          (+36.7 pct)  
  EPS             0.19 yen            2.37 yen         15.36 yen   
  Ann Div                             4.00 yen         4.00 yen    
  -Q2 div                                NIL              NIL      
  -Q4 div                             4.00 yen         4.00 yen    
   
  NOTE - Takara Bio Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Takara Bio

See all news